SUBSCRIBE
SUBSCRIBE
News   Business

Dutch Crucell N.V. Posts Q2 Net Loss, Shares Drop

August 11, 2009 | 
1 min read
Bookmark and Share

Reuters -- Dutch biotech firm Crucell NV missed estimates on Tuesday as it reported a second-quarter net loss due to delayed vaccine shipments, sending its shares to a two-month low.
Earnings
MORE ON THIS TOPIC
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
GSK restructure will hit home, impacting ‘limited’ UK roles
October 28, 2026
 · 
110 min read
 · 
BioSpace Editorial Staff
Balance vaccination and anti-vaccination. Vaccination or Anti-vaccination concept, vector illustration
Earnings
GSK vaccine sales miss expectations amid falling demand from adults
October 28, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Hand shake icon on wooden cube block which connection with human icon for business deal and agreement concept.
Immuno-oncology
Astellas bets up to $1.34B for option to advance Audax immuno-oncology asset
October 28, 2026
 · 
2 min read
 · 
Tristan Manalac
Business growth or increase in professional income, business operations, investment profits or interest on savings, increase in interest rates, businessman holding gold coins forming a growing arrow symbol.
Earnings
Biogen notches 3rd straight quarter of growth thanks to newer products, Apellis
October 28, 2026
 · 
1 min read
 · 
Annalee Armstrong